| VTCN1 |
Homo sapiens |
|
VTCN1 is differentially expressed in 44 experiments [42 up/49 dn]: 19 organism parts: white blood cells [0 up/1 dn], pancreas [1 up/0 dn], ...; 16 disease states: normal [2 up/2 dn], malignant melanoma [0 up/1 dn], ...; 9 cell types, 16 cell lines, 9 compound treatments and 9 other conditions. |
| B7H4, RP11-229A19.4-002, UNQ659/PRO1291, hCG_1810877, VTCN1 |
|
Vtcn1 (Mus musculus)
(Compare orthologs)
|
|
|
| Immunoglobulin V-set, Immunoglobulin subtype, Immunoglobulin-like, Immunoglobulin-like fold |
|
|
| immune response, integral to membrane, plasma membrane |
|
|
|
Q5T2L0
Q6P097
Q7Z7D3
|
|
|
|
ENSG00000134258
|
|
|
| Factor Value |
Factor |
Up/Down |
Legend: - number of studies the gene is up/down in
|
|
Normal
|
Disease state |
|
|
Epithelial cell
|
Cell type |
|
|
PC3
|
Cell line |
|
|
Endothelial cell
|
Cell type |
|
|
FLAP
|
Compound treatment |
|
|
HNRPA2B
|
Compound treatment |
|
|
Stromal cell
|
Cell type |
|
|
T47D
|
Cell line |
|
|
White blood cells
|
Organism part |
|
|
None
|
Compound treatment |
|
|
SKBR3
|
Cell line |
|
|
MDA468
|
Cell line |
|
|
Glucocorticoid sensitive
|
Phenotype |
|
|
BT474
|
Cell line |
|
|
Pretreatment primary sample
|
Clinical info |
|
|
SsMCF7
|
Cell line |
|
|
HPL1
|
Cell line |
|
|
HaCaT
|
Cell line |
|
|
Glucocorticoid resistant
|
Phenotype |
|
|
SKMEL5
|
Cell line |
|
|
Malignant melanoma
|
Disease state |
|
|
Epidermal growth factor
|
Compound treatment |
|
|
Pancreas
|
Organism part |
|
|
Rapamycin
|
Compound treatment |
|
|
Tumor
|
Organism part |
|
|
Cerebellum
|
Organism part |
|
|
Benign prostatic hyperplasia
|
Disease state |
|
|
Prostate carcinoma
|
Disease state |
|
|
Primary cells
|
Cell line |
|
|
Breast carcinoma
|
Disease state |
|
|
Lung
|
Organism part |
|
|
Fibroblast
|
Cell type |
|
|
Superior cervical ganglion
|
Organism part |
|
|
A549
|
Cell line |
|
|
MCF10A
|
Cell line |
|
|
Dimethyl sulfoxide
|
Compound treatment |
|
|
Not applicable
|
Histology |
|
|
Atrial mycocardium
|
Organism part |
|
|
Ventricular myocardium
|
Organism part |
|
|
MCF7
|
Cell line |
|
|
N/a
|
Test result |
|
|
Kidney
|
Organism part |
|
|
Lymphatic endothelial cell
|
Cell type |
|
|
Benign
|
Disease staging |
|
|
White blood cell
|
Cell type |
|
|
Platelet
|
Cell type |
|
|
Basal cell
|
Cell type |
|
|
Smooth muscle
|
Organism part |
|
|
Bone marrow
|
Organism part |
|
|
Umbilical cord
|
Organism part |
|
|
Adult
|
Developmental stage |
|
|
Infant
|
Developmental stage |
|
|
HL-60
|
Cell line |
|
|
Benign nevi
|
Disease state |
|
|
Metastatic
|
Disease staging |
|
|
Heregulin
|
Compound treatment |
|
|
Papillary thyroid carcinoma
|
Disease state |
|
|
BT-474
|
Cell line |
|
|
Dorsal root ganglion
|
Organism part |
|
|
Uninfected
|
Infection |
|
|
DMSO
|
Vehicle |
|
|
Baseline uninfected
|
Disease state |
|
|
Teratozoospermia
|
Disease state |
|
|
Normospermic
|
Disease state |
|
|
Spleen
|
Organism part |
|
|
Ethanol
|
Compound treatment |
|
|
Ponasterone A
|
Compound treatment |
|
|
Invasive ductal carcinoma
|
Histology |
|
|
Ciliary ganglion
|
Organism part |
|
|
CD33+ myeloid
|
Cell type |
|
|
Superficial transitional cell ...
|
Disease state |
|
|
Non-basal-like breast cancer
|
Disease state |
|
|
MDA-MB-231
|
Cell line |
|
|
Ovary
|
Organism part |
|
|
Conjunctival epithelium
|
Organism part |
|
|
Cornea epithelium
|
Organism part |
|
|
Serum starvation + thymidine b...
|
Growth condition |
|
|
Trigeminal ganglion
|
Organism part |
|
|
T-cell acute lymphoblastic leu...
|
Disease state |
|
|
Acute malaria, natural infecti...
|
Disease state |
|
|
Prostate cancer
|
Disease state |
|
|
Monoclonal gammopathy of undet...
|
Disease state |
|
|
|
|
|
Processing time: 0.063 secs.